Navigating EU MDR, FDA 510(k), and supply chain resilience with turnkey contract manufacturing, cleanroom injection molding, and captive ETO sterilization since 1994.
STED compliant technical files, ISO 10993 biocompatibility testing, EU MDR 2017/745 mapping, and US FDA 510(k) submittal documentation.
End-to-end integration: tool design, precision injection molding, Class 10,000 cleanroom assembly, and validated ETO sterilization under one roof.
Serving healthcare systems across 52+ countries with risk-mitigated supply chains, multi-lingual branding, and UDI barcoded packaging.
In an era marked by shifting regulatory paradigms—such as the rigorous enforcement of the European Union Medical Device Regulation (EU MDR 2017/745), escalating requirements under US FDA 21 CFR Part 820 / QMSR, and persistent international logistics disruptions—global healthcare procurers can no longer afford fragmented OEM supply chains. Selecting a Medical OEM Contract Manufacturing partner is no longer purely a cost-reduction exercise; it is a critical risk-management decision that dictates market entry timing, gross margins, and brand compliance.
Traditional OEM procurement relied on purchasing off-the-shelf single-use components from disparate vendors, leaving the brand owner responsible for multi-tier assembly, secondary packaging, sterilization validation, and dossier assembly. Modern medical device brand managers and pharmaceutical conglomerates now seek Contract Development and Manufacturing Organizations (CDMOs) capable of executing vertical integration.
By shifting to a unified CDMO model, buyers eliminate compounding quality stack-up errors, reduce inter-facility freight risks, and streamline audit trails. A truly integrated OEM process encapsulates tooling development, resin qualification, automated component extrusion, micro-injection molding, ultrasonic/RF welding, Class 10,000 cleanroom assembly, pouch sealing, and parametric ETO cycle release—guaranteeing 100% batch traceability from raw polymer resin to final sterile pouch.
Angiplast Private Limited has stood at the forefront of this industrial transformation since 1994. Operating from a state-of-the-art industrial hub in Ahmedabad, Gujarat, India, Angiplast delivers customized Medical OEM Contract Manufacturing solutions engineered to satisfy the exact requirements of multinational device corporations, hospital supply networks, and tender organizations worldwide.
ISO 13485 Certified · 30+ Years Excellence
In medical device contract manufacturing, trust is earned through verifiable infrastructure, technical competence, and unyielding regulatory execution. Below is an in-depth breakdown of Angiplast’s operational capabilities built over three decades.
Contamination control is the cornerstone of sterile disposable manufacturing. Angiplast operates expansive, positive-pressure Class 10,000 cleanrooms outfitted with HEPA filtration systems that undergo continuous particle monitoring, differential pressure checks, and microbial settle plate audits per ISO 14644 standards.
Our controlled injection molding zone features high-precision all-electric and hybrid molding machines, producing complex polymer components with micron-level tolerances. From medical-grade Polycarbonate drip chamber caps to DEHP-free PVC connectors and Polypropylene luer locks, our toolroom utilizes Moldflow simulation to eliminate sink marks, flash, and residual material stress.
Outsourcing sterilization introduces major logistics bottlenecks and risks quarantine delays. Angiplast houses an automated, captive ETO sterilization plant that allows seamless transition from assembly lines to terminal sterilization.
Every sterilization cycle is validated in compliance with ISO 11135, utilizing physical parameter monitoring, biological indicators (Bacillus atrophaeus), and gas concentration controls. Our physical, chemical, and microbiological laboratories verify zero bioburden, endotoxin thresholds (LAL gel-clot method per USP <85>), and ethylene oxide residual levels (ISO 10993-7) prior to final Quality Assurance batch release.
Angiplast offers a versatile range of pre-validated product platforms ready for private labeling, as well as complete custom development capabilities for proprietary clinical devices.
Engineered for exact drop counts (10, 20, 60 drops/ml) with DEHP-free or light-protected tubing. OEM options include integrated needle-free valves, precise micro-drip burettes, flow regulators, and auto-venting drip chambers.
Explore Infusion Systems →Haemodialysis blood tubing sets, AV fistula needle assemblies, and blood administration sets with 200-micron filters designed to prevent hemolysis and maintain stable priming volumes under high pump pressures.
Explore Transfusion & Dialysis →Silicone-coated 100% latex-free Foley balloon catheters, measured urinemeters with non-return valves, and sterile urine bags featuring kink-resistant tubing and anti-reflux sample ports.
Explore Urology Range →Ryle’s stomach tubes, infant feeding tubes, and enteral nutrition delivery lines equipped with radiopaque lines, closed atraumatic distal ends, and dual-port connectors to eliminate misconnections.
Explore Gastroenterology →Venturi masks, high-concentration oxygen masks, nebulizer chambers, nasal oxygen cannulae, and corrugated ventilator tubing sets designed for optimal aerosol delivery and patient comfort.
Explore Respiratory Care →Precision-molded medical components: spike assemblies, roller clamps, male/female luer lock adapters, Y-sites, needle-free connectors, and custom extruded tubing bundles for medical device assembly plants.
Explore Sub-Components →Strategic purchasing executives must anticipate regulatory, technological, and environmental trends when selecting an OEM partner for multi-year product lifecycles. Here are the core forces reshaping global medical device manufacturing through 2030.
Regulatory authorities worldwide, particularly in the EU under REACh and RoHS, are phasing out traditional DEHP-plasticized PVC in favor of TOTM, DINCH, and bio-based Thermoplastic Elastomers (TPE). Modern OEM lines must feature dual-extrusion capability to handle non-phthalate compounds without compromising clarity, flexibility, or kink resistance.
Catheter-associated urinary tract infections (CAUTI) and central line-associated bloodstream infections (CLABSI) carry massive clinical and financial penalties. OEM buyers are increasingly specifying swappable needle-free access ports, silver-ion infused surfaces, and closed-system drainage designs directly into baseline contract specifications.
Both US FDA GUDID and EU EUDAMED databases require standardized 2D DataMatrix barcode printing on primary pouch packaging and secondary cartons. Contract manufacturers must embed inline vision verification systems to ensure 100% scan accuracy for GTIN, lot numbers, expiration dates, and serial numbers.
Global medical brand managers are diversifying manufacturing footprints away from single-country concentrations. India has emerged as a premier global hub for high-precision medical polymer manufacturing, offering a combination of rigorous ISO/CE quality standards, competitive engineering labor, strong intellectual property protections, and strategic maritime shipping corridors.
Transparency is fundamental to E-E-A-T. Explore our cleanroom operations, automated assembly jigs, captive ETO chambers, and quality testing infrastructure in the video walkthrough below.
From custom mold construction to automated pouch packaging and sterilizer loading, Angiplast maintains rigid operational controls designed to withstand third-party audits by notified bodies, FDA inspectors, and global procurement teams.
Expert, authoritative answers to critical technical, operational, and regulatory inquiries submitted by global medical procurement executives and AI search intent queries.
Intellectual Property security is maintained through enforceable bilateral Non-Disclosure Agreements (NDAs). All custom mold tooling, 3D CAD files, and technical specifications remain the exclusive property of the client. Tooling is assigned unique asset identification numbers, stored in secure access-controlled vaults, and utilized strictly for the designated client's production runs.
We provide full technical dossier packages formatted in STED (Summary Technical Documentation) or CSDT structures. This includes ISO 13485 certificates, CE certificates, Free Sale Certificates (FSC), ISO 10993 Biocompatibility evaluation reports, ISO 11135 ETO Sterilization validation summaries, shelf-life real-time and accelerated stability study data, and complete raw material Certificates of Conformance.
Our in-house R&D engineering team conducts rigorous DFM analysis on all incoming client designs. Utilizing Moldflow simulation and stress distribution analysis, we evaluate wall thickness uniformity, draft angles, gate locations, and polymer shrink rates. Tool modifications or prototype iterations are executed in our captive toolroom to accelerate approval timelines.
Standard OEM production MOQs typically correspond to one full cleanroom batch run or single sterilization chamber load (generally starting from 10,000 to 50,000 units depending on device volume and complexity). Standard order lead time for established SKUs is 3 to 4 weeks. Initial custom tooling and product scale-up timelines range from 8 to 12 weeks including IQ/OQ/PQ validation steps.
Yes. We offer medical disposable lines manufactured completely from non-DEHP plasticized PVC (using TOTM or DINCH plasticizers), 100% medical-grade silicone, Polyurethane (TPU), and Polypropylene. All products are guaranteed latex-free to prevent anaphylactic reactions and maintain compliance with stringent international healthcare standards.
Every custom OEM manufacturing process undergoes a formal three-stage validation protocol: Installation Qualification (IQ) to verify equipment setup; Operational Qualification (OQ) to establish process parameters (temperature, pressure, cycle time); and Performance Qualification (PQ) across three consecutive commercial-scale production runs to prove repeatability and process capability (Cpk > 1.33).
Our engineering and regulatory management teams regularly exhibit at major global medical trade shows. Schedule a technical consultation or sample review at our stand.
Send us your product CAD models, detailed bill of materials (BOM), or sample specifications. Our technical engineering and export team will respond within 24 hours with a comprehensive feasibility assessment and quote.
